Lipid molecules induce the cytotoxic aggregation of Cu/Zn superoxide dismutase with structurally disordered regions.
Cu/Zn-superoxide dismutase (SOD1) is present in the cytosol, nucleus, peroxisomes and mitochondrial intermembrane space of human cells. More than 114 variants of human SOD1 have been linked to familial amyotrophic lateral sclerosis (ALS), which is also known as Lou Gehrig's disease. Although the ultimate mechanisms underlying SOD1-mediated cytotoxicity are largely unknown, SOD1 aggregates have been strongly implicated as a common feature in ALS. This study examined the mechanism for the formation of SOD1 aggregates in vitro as well as the nature of its cytotoxicity. The aggregation propensity of SOD1 species was investigated using techniques ranging from circular dichroism spectroscopy to fluorescence dye binding methods, as well as electron microscopic imaging. The aggregation of SOD1 appears to be related to its structural instability. The demetallated (apo)-SOD1 and aggregated SOD1 species, with structurally disordered regions, readily undergo aggregation in the presence of lipid molecules, whereas metallated (holo)-SOD1 does not. The majority of aggregated SOD1s that are induced by lipid molecules have an amorphous morphology and exhibit significant cytotoxicity. The lipid binding propensity of SOD1 was found to be closely related to the changes in surface hydrophobicity of the proteins, even at very low levels, which induced further binding and assembly with lipid molecules. These findings suggest that lipid molecules induce SOD1 aggregation under physiological conditions and exert cytotoxicity, and might provide a possible mechanism for the pathogenesis of ALS.
Choi
Inhee
I
School of Chemical and Biological Engineering, Institute of Chemical Processes, Seoul National University, Seoul 151-742, Korea.
Yang
Young In
YI
Song
Hyeon Don
HD
Lee
Jeong Seon
JS
Kang
Taewook
T
Sung
Jung-Joon
JJ
Yi
Jongheop
J
D000690:Amyotrophic Lateral Sclerosis / Q000201:enzymology; D000818:Animals; D002470:Cell Survival / Q000187:drug effects; D002942:Circular Dichroism; D006801:Humans; D057927:Hydrophobic and Hydrophilic Interactions / Q000187:drug effects; D008055:Lipids / Q000737:chemistry* / Q000494:pharmacology; D046529:Microscopy, Electron, Transmission; D016716:PC12 Cells; D011487:Protein Conformation; D051381:Rats; D013050:Spectrometry, Fluorescence; D013482:Superoxide Dismutase / Q000737:chemistry* / Q000494:pharmacology / Q000648:ultrastructure
D008055:Lipids; D013482:Superoxide Dismutase